WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
NASA's Europa Clipper survives environmental testing to prepare for launch in OctoberS. Korea's opposition bloc wins threeXi Jinping meets Ma YingHK deputies urge for linking GBA's finance, healthcare and sports sectorsChina to expedite patent application review processEuropean Parliament adopts new migration, asylum pactChina's mega water diversion project benefits over 176 mln peopleECB leaves interest rates unchangedChinese mainland warns against Taiwan military's provocationsCao Maoyuan: Chinese athlete shines as first gold medalist at Chengdu Universiade
3.3022s , 6501.609375 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Global Gazette news portal